Risedronate rapidly and consistently reduces risk of vertebral fracture in patients with varying degrees of osteoporotic severity.

被引：0
作者：
Cohen, S
Roux, C
Eastell, R
Mulder, H
Harris, ST
Pack, S
Watts, NB
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
786
引用
收藏
页码：S197 / S197
页数：1
相关论文
共 50 条
[21]   Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: A systematic literature review [J].
Ruyssen-Witrand, A. ;
Gossec, L. ;
Kolta, S. ;
Dougados, M. ;
Roux, C. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (09) :1271-1278
[22]   Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review [J].
A. Ruyssen-Witrand ;
L. Gossec ;
S. Kolta ;
M. Dougados ;
C. Roux .
Osteoporosis International, 2007, 18 :1271-1278
[23]   Risedronate significantly reduces the risk of non-vertebral fractures in postmenopausal osteoporotic women in just one year. [J].
Bolognese, M ;
Fogelman, I ;
Guesens, P ;
Hanley, DA ;
Barton, I ;
Bettica, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 :S404-S404
[24]   Risedronate therapy reduces the risk of new vertebral fractures by 60% in osteoporotic men with osteoporosis within 1 year. [J].
Ringe, J ;
Faber, H ;
Salem, M ;
Grauer, A ;
Möller, G .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 :S441-S441
[25]   Strontium ranelate reduces the risk of vertebral fracture in patients with osteopenia [J].
Seeman, E. ;
Sawicki, A. ;
Reginster, J. Y. ;
Roux, C. ;
Rubinacci, A. ;
Diaz-Curiel, M. ;
Kaufman, J. M. ;
De Vernejoul, M. C. ;
Aquino, J. P. ;
Meunier, P. J. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 :S209-S209
[26]   Strontium ranelate reduces the risk of vertebral fracture in patients with osteopenia [J].
Seeman, E. ;
Sawicki, A. ;
Reginster, J. -Y. ;
Roux, C. ;
Rubinacci, A. ;
Diaz-Curiel, M. ;
Kaufman, J. -M. ;
de Vernejoul, M. C. ;
Aquino, J. P. ;
Meunier, P. J. .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 :S50-S50
[27]   Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy [J].
Reid, DM ;
Adami, S ;
Devogelaer, JP ;
Chines, AA .
CALCIFIED TISSUE INTERNATIONAL, 2001, 69 (04) :242-247
[28]   Risedronate reduces vertebral fracture risk after the first year of treatment in postmenopausal women with established osteoporosis. [J].
Watts, N ;
Roux, C ;
Genant, H ;
Adami, S ;
Hangartner, T ;
Miller, P ;
Sorensen, O ;
Hooper, M ;
Ethgen, D ;
Valent, D .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 :S136-S136
[29]   Correction to: Re‑fracture and correlated risk factors in patients with osteoporotic vertebral fractures [J].
Xinling Ma ;
Haiou Xia ;
Jinhua Wang ;
Xiaoxiao Zhu ;
Fangyan Huang ;
Liuxue Lu ;
Lanyan He .
Journal of Bone and Mineral Metabolism, 2019, 37 :729-729
[30]   Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy [J].
D.M. Reid ;
S. Adami ;
J.-P. Devogelaer ;
A.A. Chines .
Calcified Tissue International, 2001, 69 :242-247
12345